PR26-0317

Summary

A DC resolution to approve rulemaking on medical cannabis remediation and testing standards, currently referred to the Committee on Business and Economic Development. Updated remediation and testing rules would affect the standards laboratories and dispensaries must meet for product safety compliance.

More Washington, D.C. Cannabis Bills

• B26-0759Medical Cannabis Licensing and Unlicensed Establishment Enforcement Clarification Emergency Amendment Act of 2026Passed
• B26-0760Medical Cannabis Licensing and Unlicensed Establishment Enforcement Clarification Temporary Amendment Act of 2026In Committee
• PR26-0779Medical Cannabis Licensing and Unlicensed Establishment Enforcement Clarification Emergency Declaration Resolution of 2026Passed
• PR26-0674Alcoholic Beverage and Cannabis Board James Turner Confirmation Resolution of 2026Passed Chamber
• PR26-0673Alcoholic Beverage and Cannabis Board Monte Monash Confirmation Resolution of 2026Introduced
• B26-0654Medical Cannabis Beverage Product Amendment Act of 2026Introduced
• PR26-0568Medical Cannabis Qualifying Patient Application Approval Resolution of 2026Introduced
• B26-0345Medical Cannabis Conditional Licensure Extension Temporary Amendment Act of 2025Passed
• B26-0300Streatery Program Endorsement Extension and Medical Cannabis Clarification Temporary Amendment of 2025Passed
• B26-0522Medical Cannabis Process Improvement Amendment Act of 2025Introduced
• B26-0386Streatery Program Endorsement Extension and Medical Cannabis Clarification Congressional Review Emergency Amendment Act of 2025Passed
• B26-0344Medical Cannabis Conditional Licensure Extension Emergency Amendment Act of 2025Passed